CClinicalTrials.gg
TerminatedNCT00738491Updated Dec 2, 2014

Effects of Ambient Air Pollution Exposure in Patients With Stable Angina Pectoris During Normal Daily Activities

An observational study in Angina Pectoris and Coronary Heart Disease, sponsored by University of Edinburgh. Terminated at 2 sites in United Kingdom. Per ClinicalTrials.gov, last updated 2014-12-02.

Sponsored by University of Edinburgh · Observational

Why this study was terminated
Study performed in alternative location (Beijing China)
Study type
Observational
Model
Case-crossover
Time perspective
Prospective
Enrollment
1
Sex
All
01

Study summary

The purpose of this study is to identify whether exposure to ambient levels of air pollution during normal daily activities has a functional impact on patients with coronary heart disease

Read the detailed description

Exposure to air pollution has been shown in epidemiological studies to be closely linked to cardiovascular morbidity and mortality. The exact components of air pollution that underlie the cardiovascular effects are not yet known, but combustion-derived particulate matter is suspected to be the major cause. In controlled exposure studies, we have recently demonstrated that exposure to diesel exhaust causes increased myocardial ischaemia with exercise in patients with asymptomatic coronary artery disease. The mechanism behind this effect is not yet understood, but we have shown that diesel exhaust exposure causes an acute impairment of two important and highly relevant aspects of vascular tone: vasomotor tone and endogenous fibrinolysis. In this study we propose to investigate the effects of exposure to ambient levels of air pollution on patients with stable, symptomatic angina pectoris, during their daily lives.

02

Conditions studied

  • Angina Pectoris
  • Coronary Heart Disease

Keywords

  • Angina pectoris
  • Exercise capacity
  • Myocardial ischaemia
  • Air pollution
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 1 is below the median of 294 across 1,241 observational studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

University of Edinburgh is the lead sponsor of 393 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with stable angina pectoris and documented coronary artery disease

Inclusion criteria

  • Documented coronary artery disease
  • Symptoms of stable angina pectoris
  • Positive BRUCE exercise stress test between 3 and 13 minutes

Exclusion criteria

Exclusion Criteria:

  • History of arrhythmia
  • Severe 3 vessel coronary disease or left main stem stenosis that has not been revascularised
  • Resting conduction abnormality
  • Digoxin therapy
  • Uncontrolled hypertension
  • Renal or hepatic failure
  • Unstable symptoms or acute coronary syndrome within 3 months
05

Study design

Observational model
Case-crossover
Time perspective
Prospective
Enrollment
1 participant (actual)
Biospecimen retention
Samples without dna

Groups and cohorts

  • 1

    Patients with stable angina pectoris and documented coronary heart disease recruited in Edinburgh

  • 2

    Patients with stable angina pectoris and documented coronary heart disease recruited in London

06

What researchers measure

Primary outcomes

  1. Symptoms of angina pectoris - assessed by symptom diary and reliever medication usage

    Time frame: Throughout study period

Secondary outcomes

  1. Myocardial ischaemic burden - assessed using 12-lead continuous Holter ECG monitoring

    Time frame: Throughout study period

  2. Time to 1mm ST segment depression during standard BRUCE exercise stress testing

    Time frame: At the end of the study period

  3. Total exercise capacity - measured using GPS tracking of activity completed

    Time frame: Throughout study period

  4. Exercise capacity - determined by standard BRUCE exercise stress testing

    Time frame: Immediately after study period

  5. Ambulatory blood pressure

    Time frame: Throughout study period

  6. Biochemical evidence of myocardial ischaemia - highly sensitive troponin, ischaemically modified albumin and fatty acid binding protein

    Time frame: Before and after study period

07

Study locations

2 sites
  • University of Edinburgh
    Edinburgh, Midlothian EH16 4SB, United Kingdom
  • Imperial College
    London, SW3 6LY, United Kingdom
08

References and documents

Publications

  • McCreanor J, Cullinan P, Nieuwenhuijsen MJ, Stewart-Evans J, Malliarou E, Jarup L, Harrington R, Svartengren M, Han IK, Ohman-Strickland P, Chung KF, Zhang J. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med. 2007 Dec 6;357(23):2348-58. doi: 10.1056/NEJMoa071535. PubMed 18057337 ↗
  • Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med. 2007 Sep 13;357(11):1075-82. doi: 10.1056/NEJMoa066314. PubMed 17855668 ↗
  • Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, Macnee W, Donaldson K, Soderberg S, Newby DE, Sandstrom T, Blomberg A. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med. 2007 Aug 15;176(4):395-400. doi: 10.1164/rccm.200606-872OC. Epub 2007 Apr 19. PubMed 17446340 ↗
  • Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005 Dec 20;112(25):3930-6. doi: 10.1161/CIRCULATIONAHA.105.588962. PubMed 16365212 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00738491
Lead sponsor
University of Edinburgh
Collaborators
Imperial College London
Responsible party
Jeremy Langrish (Clinical Lecturer and Specialty Registrar in Cardiology, University of Edinburgh) — Principal investigator
First posted
Aug 20, 2008
Start date
Aug 2008
Primary completion
Aug 2013
Completion
Aug 2013
Last update
Dec 2, 2014

Study contacts

Jeremy P Langrish, MB BCh
principal investigator · University of Edinburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion